Starpharma Holdings Ltd has released a press release.
VIRALEZE UK Update
Filed with ASX ·
On 6ix: 6ix.com/news/viraleze-uk-update
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VIRALEZE SPL7013 virucidal against multiple COVID variants
- VIRALEZE antiviral nasal spray registered for sale in India
- VIRALEZE SPL7013 highly active in UK variant of coronavirus
- VIRALEZE launches in Europe
- VIRALEZE™ now launched by LloydsPharmacy in the UK
Later from Starpharma
- VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
- VIRALEZE well tolerated in multiple dose clinical study
- VIRALEZE Protects Against SARS-CoV-2 in Challenge Model
- VIRALEZE launch in ADMENTA Italia Group pharmacies in Italy
- VIRALEZE distribution and supply to Vietnam
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma